Brandes Investment Partners' Q3 vs. Q4 2022 13F Holdings Comparison: Insights into Changes in Holdings Over the Past Quarter.
Ava Hoppe | 20 April, 2023
Brandes Investment Partners, LP Q3 2022 vs. Q4 2022 13F Holdings Comparison
Brandes Investment Partners, LP has released its Q3 2022 vs. Q4 2022 13F holdings comparison, which provides an interesting insight into the fund's changes in holdings over the past quarter. The 13F filing shows the fund's top holdings as of the end of the quarter, broken down by the issuer name, option type, and changes in shares and value. Here is a summary of the top holdings:
1. EMBRAER S.A. - Option Type: None - Change in Shares: -3,615,103 (-19%) - Change in Value: 8,106 (5%)
Brandes Investment Partners has reduced its holdings of EMBRAER S.A. by 19% during the quarter, with a corresponding decrease in value of 5%. This is a significant reduction in holdings, indicating a potential change in the fund's investment strategy.
2. CEMEX SAB DE CV - Option Type: None - Change in Shares: -4,135,966 (-12%) - Change in Value: 4,797 (4%)
Brandes Investment Partners has also reduced its holdings of CEMEX SAB DE CV by 12% during the quarter, with a corresponding decrease in value of 4%. This is a smaller reduction in holdings, but still significant in terms of the overall value of the fund's holdings.
3. WELLS FARGO CO NEW - Option Type: None - Change in Shares: -350,526 (-11%) - Change in Value: -11,067 (-9%)
Brandes Investment Partners has decreased its holdings of Wells Fargo by 11% during the quarter, with a corresponding decrease in value of 9%. This may reflect a change in the fund's perception of the company's future growth prospects.
4. CHEVRON CORP NEW - Option Type: None - Change in Shares: -28,713 (-4%) - Change in Value: 17,749 (19%)
Brandes Investment Partners has reduced its holdings of Chevron by 4% during the quarter, but the corresponding increase in value of 19% indicates that the fund has confidence in the company's future prospects.
5. CIGNA CORP NEW - Option Type: None - Change in Shares: -158,105 (-34%) - Change in Value: -27,014 (-21%)
Brandes Investment Partners has significantly reduced its holdings of Cigna by 34% during the quarter, with a corresponding decrease in value of 21%. This represents a major shift in the fund's investment strategy and may indicate a loss of confidence in the company's future prospects.
6. HALLIBURTON CO - Option Type: None - Change in Shares: -33,755 (-11%) - Change in Value: 30,135 (42%)
Brandes Investment Partners has decreased its holdings of Halliburton by 11% during the quarter, with a corresponding increase in value of 42%. This suggests that the fund remains confident in the company's future prospects despite the reduction in holdings.
7. PFIZER INC - Option Type: None - Change in Shares: -32,654 (-14%) - Change in Value: 731 (1%)
Brandes Investment Partners has decreased its holdings of Pfizer by 14% during the quarter, with a corresponding increase in value of 1%. This indicates some uncertainty about the company's future prospects, but the increase in value suggests that the fund sees some upside potential.
8. MERCK & CO INC - Option Type: None - Change in Shares: -31,550 (-26%) - Change in Value: -5,555 (-5%)
Brandes Investment Partners has decreased its holdings of Merck by 26% during the quarter, with a corresponding decrease in value of 5%. This represents another major shift in the fund's investment strategy and may indicate a loss of confidence in the company's future prospects.
9. MCKESSON CORP - Option Type: None - Change in Shares: -32,415 (-11%) - Change in Value: -2,071 (-2%)
Brandes Investment Partners has reduced its holdings of McKesson by 11% during the quarter, with a corresponding decrease in value of 2%. This may reflect a cautious approach to the company's future prospects.
10. BANK AMERICA CORP - Option Type: None - Change in Shares: -38,003 (-12%) - Change in Value: -3,282 (-3%)
Brandes Investment Partners has reduced its holdings of Bank of America by 12% during the quarter, with a corresponding decrease in value of 3%. This may reflect a cautious approach to the banking sector in general, or a specific concern about the company's future prospects.
Conclusion
The Q3 2022 vs. Q4 2022 13F holdings comparison provides a useful snapshot of Brandes Investment Partners, LP's changes in holdings over the past quarter. While some reductions in holdings may reflect a cautious approach to certain companies or sectors, others may represent a loss of confidence in the company's future prospects. As with any investment strategy, it is important to carefully evaluate a fund's holdings and investment objectives before making any investment decisions.
Other Posts
- Analyzing Palladium Partners LLC's Q4 2021 vs. Q1 2022 13F Holdings: What Do the Changes Mean for Investors?
- Sunny Sky Products Expands Beverage Solutions Portfolio with Bevolution Group Acquisition
- PDS Planning, Inc Q1 2023 vs. Q2 2023 13F Holdings Comparison
- Kohmann Bosshard Financial Services, LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison
- Solstein Capital’s Q4 2022 vs Q1 2023 13F Holdings Comparison
- Navigating the Winds of Change: How Financial Enhancement Group's Portfolio Transformed from Q4 2023 to Q1 2024
- Rampart Investment Management's Dramatic Shift in Holdings: Q3 2020 vs. Q4 2020
- Unity Partners Announces Partnership with Tropolis: Revolutionizing the Insurance Brokerage Industry
- Stevens First Principles Investment Advisors Q1 2019 vs. Q2 2019 13F Holdings Comparison: Analyzing Changes in Top Stock Picks
- Analyzing Copernicus Capital's Q2 vs. Q3 2021 13F Holdings: Winners and Losers